Tom Powles ✓

@tompowles1 · joined 16 Dec 2019

Interested in Urology Cancers, biomarkers and drug development.

13 951Followers

88Following

2 562Posts total

84.4KViews on collected posts

Ultimi post

Tom Powles ✓@tompowles118 Sep

How do we sequence ADCs after EVP in advanced bladder cancer. @DrRosenbergMSK Switching payload appears more important than switching target. iZABREN (HER1/3 Topo1) vs platinum chemo and SACTMT (TROP2/TOPO1 vs taxane) in EVP resistant disease are enrolling #GuardSymposium2026 htt

859 views · 10 likes · 8 reposts · 0 replies Open on X →

Tom Powles ✓@tompowles118 Sep

Will there be local relapses when we pursue surgery sparing approaches with EVP and without radiotherapy in muscle invasive bladder cancer (EV209/EV309) @AndreaNecchi . Can we reduce this risk with local therapy (TAR200 BCG etc) #GuardSymposium2026 https://t.co/RzVIAKWau2

434 views · 11 likes · 5 reposts · 0 replies Open on X →

Tom Powles ✓@tompowles118 Sep

While PD-L1 has been inconsistent as a biomarker in UC, T cell effector signatures have correlated with response to ICI therapy #Guardsymposium26. The data presented by @scocmem shows this signature is associated with poor rather than good outcomes with BCG. This initially https:

903 views · 19 likes · 12 reposts · 0 replies Open on X →

Tom Powles ✓@tompowles129 Aug

After the positive press release for the Moderna personalised cancer vaccine (adjuvant therapy in combo with pembro in melanoma) we get a negative press release (‘imbalances in OS’ ➡️early termination) for the BioNTech PCV (monotherapy, sequenced after chemo, in ctDNA+ve adjuvant

43.4K views · 100 likes · 31 reposts · 14 replies Open on X →

Tom Powles ✓@tompowles119 Aug

Personalized mRNA-based neoantigen vaccines + pembo are being tested in a number of randomised adjuvant cancer trials (included bladder and renal). The 1st positive trial (RIII in melanoma) was announced today. PCVs are logistically complex with limited monotherapy activity in h

21.2K views · 157 likes · 39 reposts · 7 replies Open on X →

Tom Powles ✓@tompowles124 Jul

@tompowles1 @DrChoueiri Congrats @DrChoueiri very well deserved! 154 views · 3 likes · 0 reposts · 0 replies Open on X →

Tom Powles ✓@tompowles124 Jul

@tompowles1 @DrChoueiri A real Giant in Oncology!!! 335 views · 3 likes · 1 reposts · 0 replies Open on X →

Tom Powles ✓@tompowles124 Jul

@tompowles1 @DrChoueiri Wow Toni! 👏👏👏 132 views · 3 likes · 1 reposts · 0 replies Open on X →

Tom Powles ✓@tompowles123 Jul

Toni Choueiri @DrChoueiri receiving the lifetime achievement award #KCRS26 . Leading a plethora of practice changing trials from METEOR to LITESPARK. >900 publications. Amazing achievement and well deserved. https://t.co/rMlAc2lZng

17K views · 198 likes · 31 reposts · 14 replies Open on X →

Rispetto ad account della stessa dimensione

5 post degli ultimi 90 giorni, accanto alla fascia di 10K–100K follower. arriva ben oltre il proprio pubblico, e quel pubblico reagisce.

Visualizzazioni mediane903questo account924mediana per 10K–100K

Copertura, %6.47%questo account3.62%mediana per 10K–100K

Interazione, %2.21%questo account1.52%mediana per 10K–100K

Metrica	Questo account	Mediana per 10K–100K	Rapporto
Visualizzazioni mediane per post	903	924	0.98×
Copertura (visualizzazioni ÷ follower)	6.47%	3.62%	1.79×
Tasso di interazione	2.21%	1.52%	1.45×

Altri account di questa fascia → Confronta con un altro account → Come sono costruiti questi parametri →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

17K23 Jul

13224 Jul

335

154

21.2K19 Aug

43.4K29 Aug

90318 Sep

434

859

Last 9 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.47%23 Jul

3.03%24 Jul

1.19%

1.95%

0.98%19 Aug

0.34%29 Aug

3.43%18 Sep

3.69%

2.21%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes70.1%504 in total

Reposts17.8%128 in total

Replies4.9%35 in total

Quotes2.1%15 in total

Bookmarks5.1%37 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Ultimi post

Rispetto ad account della stessa dimensione

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Account simili